Status:
NOT_YET_RECRUITING
Characterising the Loss of Haemostasis in Haemorrhagic Fever With Renal Syndrome
Lead Sponsor:
Liverpool School of Tropical Medicine
Collaborating Sponsors:
Institute of microbiology and immunology, Slovenia
Conditions:
Haemorrhagic Fever With Renal Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Hantaviruses are globally distributed viruses that cause haemorrhagic fever with renal syndrome (HFRS) in Europe, a disease characterised by acute kidney failure and, in some cases, significant bleedi...
Detailed Description
Hantaviruses are globally distributed viruses that are transmitted to humans through the inhalation of viral particles found in the urine and faeces of infected rodents. In Europe, hantaviruses cause ...
Eligibility Criteria
Inclusion
- Patients aged 18 or older, including pregnant women
- Laboratory-confirmed HFRS (serology and/or RT-PCR)
- Willing and able to provide informed consent
Exclusion
- Patients under 18 years of age
- Co-infections with other pathogens
- Pre-existing coagulation disorders
- Use of anticoagulant medication
- Inability or refusal to provide consent
Key Trial Info
Start Date :
May 1 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2027
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT06944275
Start Date
May 1 2026
End Date
August 31 2027
Last Update
November 19 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.